Caldera Medical, Inc.

Caldera Medical, Inc. is a U. S. -based company focused on developing innovative medical solutions for women's pelvic health, particularly addressing stress urinary incontinence and pelvic organ prolapse.

Founded in 2002 in Westlake Village, US, Caldera Medical, Inc. specializes in medical solutions for women's health. The company was established by professionals with prior experience in the healthcare sector, although specific founding individuals are not mentioned. Caldera Medical's operations have remained consistent with their focus on pelvic health solutions.

Currently, Bryon Merade serves as the CEO, leading the company toward its mission without any known changes in ownership structure or subsidiaries. Caldera Medical specializes in innovative medical solutions aimed at addressing women's pelvic health issues, specifically focusing on stress urinary incontinence (SUI) and pelvic organ prolapse (POP). The core product offerings include effective treatments for SUI, enhancing patients' quality of life, along with durable solutions for POP. Additionally, the company provides advanced hysteroscopic tissue removal products designed for precise diagnosis and treatment of various uterine conditions.

These products cater primarily to healthcare providers, including surgeons and clinics, serving women with these health issues across North America and select international markets, with a commitment to reach one million women by 2027 through treatment and education initiatives. Caldera Medical generates revenue primarily through direct sales of its medical products to healthcare facilities and practitioners specializing in women's health. The transaction structure involves partnerships with healthcare providers, where products are purchased outright or through contractual agreements for ongoing supply. The flagship offerings for SUI and POP are designed to meet healthcare practitioners' demand for effective solutions.

Pricing plans are structured to reflect the value of these innovative solutions, although specific pricing details remain proprietary. The company maintains a focus on physician education and engagement, fostering an environment conducive to repeat business and long-term partnerships in the healthcare sector. Caldera Medical's strategy for future growth includes the design and launch of new products focused on expanding treatment options for women's pelvic health issues. The company plans to enter additional international markets, particularly in Europe and Asia, by 2025.

Recent funding is expected to support these initiatives, enhancing product development and market entry strategies. The company aims to solidify its presence in these new regions while continuing to expand its product line to better serve healthcare providers and their patients.